MedPath

2D Perfusion DSA for the Quantification of Infrapopliteal Angioplasty

Not Applicable
Completed
Conditions
Ischemia Limb
Interventions
Diagnostic Test: 2D perfusion digital subtraction angiography of the foot.
Registration Number
NCT04356092
Lead Sponsor
Attikon Hospital
Brief Summary

A custom-made, 2D-perfusion digital subtraction angiography (PDSA) algorithm has been designed and implemented towards foot perfusion quantification following endovascular treatment of critical limb ischemia (CLI), in order to assist intra-procedural decision-making and enhance clinical outcomes.

Detailed Description

This is a prospective, single-center, study investigating the feasibility of 2D-PDSA using newly-developed, non-commercially available, color-coded software for the quantification of foot perfusion following infrapopliteal angioplasty for the treatment of CLI. In total, 7 consecutive patients scheduled to undergo infrapopliteal endovascular treatment of CLI were enrolled. Perfusion Blood Volume (PBV), Mean Transit Time (MTT), and Perfusion Blood Flow (PBF) maps were extracted by analyzing Time-Intensity Curves and signal intensity on the perfused vessel mask. Mean values calculated from user-specified ROIs on perfusion maps were employed to evaluate the patient's pre- and post- endovascular treatment condition.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Patients prescheduled for infrapopliteal angioplasty due to chronic limb-threatening ischemia.
  • Written informed consent obtained
Exclusion Criteria
  • Image post-processing not feasible due to significant motion artifacts produced during DSA

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Perfusion2D perfusion digital subtraction angiography of the foot.Consecutive patients scheduled to undergo infrapopliteal angioplasty or stenting, or both, as part of their standard treatment for Rutherford-Becker class 5 and 6 chronic limb-threatening ischemia, were included in the study. All procedures were performed using local anesthesia. An antegrade access was used in all patients followed by the deployment of a 5 or 6 Fr arterial sheaths. A semi-lateral foot projection was preferred and the pre-revascularization DSA of the foot was performed via a 5 Fr angiographic catheter placed at the distal third of the popliteal artery. Following revascularization of one or more tibial arteries, the catheter was placed at the same popliteal segment and post-procedural DSA of the foot was performed following the exact pre-revascularization injection protocol at the same semi-lateral projection. The 2D-perfusion imaging and analysis of the DICOM files was performed after revascularization.
Primary Outcome Measures
NameTimeMethod
Change in Perfusion Blood Flow (PBF)Ten minutes before and five minutes after the intervention

PBF calculated on subtraction images and pre- and post-procedural values compared using the proposed 2D perfusion DSA software.

Change in Perfusion Blood Volume (PBV)Ten minutes before and five minutes after the intervention

PBV calculated on subtraction images and pre- and post-procedural values were compared using the proposed 2D perfusion DSA software.

Change in Mean Transit Time (MTT)Ten minutes before and five minutes after the intervention

MTT calculated on subtraction images and pre- and post-procedural values were compared using the proposed 2D perfusion DSA software.

Secondary Outcome Measures
NameTimeMethod
Major amputation rateSix months

The rate of above the knee target limb amputation

Procedure-related complications30 days

Complications noted during and after the index procedure

Trial Locations

Locations (1)

Patras University Hospital

🇬🇷

Patras, Achaia, Greece

© Copyright 2025. All Rights Reserved by MedPath